Hing C. Wong - Sep 8, 2021 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Executive Officer, Director
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Hing C. Wong
Stock symbol
HCWB
Transactions as of
Sep 8, 2021
Transactions value $
$0
Form type
4
Date filed
9/10/2021, 05:44 PM
Previous filing
Oct 7, 2021
Next filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCWB Stock Option (Right to Buy) Award $0 +800K $0.00 800K Sep 8, 2021 Common Stock 800K $4.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025.